Vincent Woo

23.7k citations
93 papers · 4.6k · 2 hit papers · h-index 33

Impact in

Papers in

    • Diabetes Treatment and Management 63
    • Diabetes Management and Research 42
    • Hyperglycemia and glycemic control in critically ill and hospitalized patients 8
    • Diabetes, Cardiovascular Risks, and Lipoproteins 5
    • Pancreatic function and diabetes 20

Vincent Woo

91 papers receiving 4.4k citations

Vincent Woo's Hit Papers

Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial 2019 · 279 citations
2790+6+12Years since publication100200300400500

Peers

Vincent Woo
Comparison fields: 5 of 102
  • Endocrinology, Diabetes and Metabolism 3.5k
  • Pharmacology 420
  • Surgery 1.0k
  • Nephrology 119
  • Molecular Biology 911
Replace Eleni Bekiari with:
Eleni Bekiari Greece
Samuel S. Engel United States
Andrew Lewin United States
Peter P. Stein United States
Jaime A. Davidson United States
Peter Öhman United States
Paul D. Rosenblit United States
William Canovatchel United States
Steven G. Terra United States
Shamik Parikh United States
Vincent Woo relative to Eleni Bekiari Greece Eleni Bekiari's profile →
Citations per field
00.5×2.9×
Eleni Bekiari · 1×
Citations per year

Countries citing papers authored by Vincent Woo

Since Specialization
Citations

This map shows the geographic impact of Vincent Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Woo more than expected).

Fields of papers citing papers by Vincent Woo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Woo. The network helps show where Vincent Woo may publish in the future.

Co-authors

The 25 scholars most cited alongside Vincent Woo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Vincent Woo Line = papers co-authored together Vincent Woo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
Hit paper breakdown →
2008575
2
Semaglutide once weekly as add-on to SGLT-2 inhibitor therapy in type 2 diabetes (SUSTAIN 9): a randomised, placebo-controlled trial
Hit paper breakdown →
2019279
3 2014266
4 2013245
5 2016234
6 2016223
7 2019203
8 2015186
9 2001138
10 2014120
11 2013119
12 2017113
13 2017111
14 2013111
15 2015100
16 201493
17 201977
18 201575
19 202369
20 201369

About Vincent Woo

Vincent Woo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Molecular Biology, Genetics and Pharmacology, having authored 93 papers that have together received 4.6k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (63 papers), Diabetes Management and Research (42 papers), Pancreatic function and diabetes (20 papers), Metabolism, Diabetes, and Cancer (12 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (8 papers), Diabetes and associated disorders (8 papers), Pharmacology and Obesity Treatment (7 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (3.5k citations), Pharmacology (420 citations), Surgery (1.0k citations), Nephrology (119 citations) and Molecular Biology (911 citations). Vincent Woo has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include James F. List, Weihua Tang, Fred T. Fiedorek, Enrique Morales, Bernard Zinman, Bruce W. Bode, Lori Berard, Stephen Gough, Jean‐François Yale and Ronald Goldenberg. Their work appears in journals such as Canadian Journal of Diabetes, Diabetes Obesity and Metabolism, Diabetes Care, Diabetes Therapy and International Journal of Clinical Practice.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact